MedPath

Vision Restoration Training in Glaucoma

Phase 2
Completed
Conditions
Glaucoma
Registration Number
NCT01799707
Lead Sponsor
University of Magdeburg
Brief Summary

Importance: Visual field loss after retinal damage in glaucoma is considered irreversible and methods are needed to achieve vision restoration. Behavioral vision restoration training (VRT), shown to improve visual fields in hemianopia and optic nerve damage, might comprise such a method.

Objective: To determine if behaviorally activating areas of residual visual (ARV) using VRT by daily one hour training for 3 months improves detection performance in perimetry compared to a vision discrimination task in the intact visual field sector.

Detailed Description

Design: Prospective, randomized, double-blind, placebo controlled trial. Setting: Ambulatory care and home training Participants: Volunteer sample of glaucoma patients (25-80 yrs old) with stable visual fields and well controlled intraocular pressure (IOP).

Intervention: Computer-based home training with VRT (n=15) or placebo discrimination training (n=15).

Main Outcome Measures: The primary endpoint is change in detection performance in High Resolution Perimetry (HRP). Secondary endpoints are 30° white/white and 30° blue/yellow near-threshold perimetry. Further measures are eye movements, vision-related quality of life (vQoL) as assessed with (NEI-VFQ) and health-related quality of life (hQoL) using SF-36 Health Survey-Short Form.

Investigators hypothesize that VRT will improve visual performance in glaucoma

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Visual filed defect caused by glaucoma
  • Presence of a reproducible and stable visual field defect inside 30° eccentricity in at least one eye in 2 consecutive ophthalmologic visits during the last 12 months before recruitment
  • Well controlled intraocular pressure (IOP), and (iv) age between 25 and 80 years
Exclusion Criteria
  • History of any medical condition precluding scheduled study visits or completion of the study (e.g. unstable cardiovascular disease)
  • History of any chronic degenerative or chronic inflammatory disease that could affect the visual field (e.g. multiple sclerosis, tumor
  • History of trauma or any non-glaucoma ocular diseases (e.g. diabetic retinopathy, age-related macular degeneration, macular detachment, vascular occlusion
  • Severe cognitive or motor impairments
  • Insufficient fixation ability
  • Photosensitivity
  • Intraocular surgery or laser treatment performed within the previous 12 months before recruitment; OR
  • Scheduled intraocular surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Detection accuracy change in percent over baseline of the visual fieldbetween baseline and 3 months of training

visual stimulus detection in residual and absolutely defect field of vision will be assessed using computer-based high resolution perimetry (HRP)

Secondary Outcome Measures
NameTimeMethod
change in visual stimulus perimetric detection ratebetween baseline and 3 months of training

improvement of visual field in near-threshold perimetry measured by static perimetry (average threshold in db, average excentricity in degrees of visual angle

improvement of reaction timebetween baseline and 3 months of training

change in average reaction time in ms, measured by HRP

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.